analysis of impassion130: pd-l1 testing in advanced tnbc
Published 4 years ago • 119 plays • Length 4:27Download video MP4
Download video MP3
Similar videos
-
6:56
impassion130 trial data on pd-l1 tumors in tnbc
-
4:47
tnbc: updated efficacy results from impassion130
-
4:46
performance of pd-l1 ihc assays in impassion130: a post-hoc analysis
-
2:51
impassion130: design and preliminary efficacy
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
6:54
impassion130 trial data on pd-l1 tumors in tnbc
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
1:38
combined analyses of pd-l1 and tils for therapy selection in tnbc
-
8:42
chemoimmunotherapy in tnbc: the impassion130 trial
-
4:33
i-o in tnbc: impassion130 trial design and results
-
4:27
the impassion130 study in metastatic tnbc
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
2:44
impassion130: addressing immune-related aes in tnbc management
-
1:16
the impassion130 trial in metastatic triple-negative breast cancer
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
2:33
applying impassion130 data to tnbc management
-
1:46
dr. schmid discusses the findings of impassion130 in tnbc
-
3:37
case 3: pd-l1 testing used in triple-negative breast cancer
-
4:22
neotripapdl1: dynamics of tils & pd-l1 expression in breast cancer